留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

应中央军委要求,2022年9月起,《药学实践杂志》将更名为《药学实践与服务》,双月刊,正文96页;2023年1月起,拟出版月刊,正文64页,数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿!

网络药理学在中药作用机制中的研究进展

邢心睿 吕狄亚 柴逸峰 朱臻宇

邢心睿, 吕狄亚, 柴逸峰, 朱臻宇. 网络药理学在中药作用机制中的研究进展[J]. 药学实践与服务, 2018, 36(2): 97-102. doi: 10.3969/j.issn.1006-0111.2018.02.001
引用本文: 邢心睿, 吕狄亚, 柴逸峰, 朱臻宇. 网络药理学在中药作用机制中的研究进展[J]. 药学实践与服务, 2018, 36(2): 97-102. doi: 10.3969/j.issn.1006-0111.2018.02.001
XING Xinrui, LÜ Diya, CHAI Yifeng, ZHU Zhenyu. Advances in the mechanism of Traditional Chinese Medicine by network pharmacology method[J]. Journal of Pharmaceutical Practice and Service, 2018, 36(2): 97-102. doi: 10.3969/j.issn.1006-0111.2018.02.001
Citation: XING Xinrui, LÜ Diya, CHAI Yifeng, ZHU Zhenyu. Advances in the mechanism of Traditional Chinese Medicine by network pharmacology method[J]. Journal of Pharmaceutical Practice and Service, 2018, 36(2): 97-102. doi: 10.3969/j.issn.1006-0111.2018.02.001

网络药理学在中药作用机制中的研究进展

doi: 10.3969/j.issn.1006-0111.2018.02.001
基金项目: 国家自然科学基金(81773683)

Advances in the mechanism of Traditional Chinese Medicine by network pharmacology method

  • 摘要: 网络药理学以系统生物学为基础,系统阐述了机体与药物相互作用的原理与规律,代表了现代生物医药的哲学理念与研究模式。运用网络药理学相关的技术手段,更便于理解中药治疗疾病的作用机制,目前网络药理学已被广泛应用于中药研究。从网络药理学及网络药理学应用等方面,介绍近年网络药理学在中药领域的运用与发展。
  • [1] Hopkins AL. Network pharmacology:the next paradigm in drug discovery[J]. Nat Chem Biol,2008,4(11), 682-690.
    [2] Fang J, Wang L, Wu T,et al. Network pharmacology-based study on the mechanism of action for herbal medicines in Alzheimer treatment[J]. J Ethnopharmacol,2017,196:281-292.
    [3] 李梢.网络靶标:中药方剂网络药理学研究的一个切入点[J].中国中药杂志,2011,36(15):2017-2020.
    [4] Yang M, Chen JL, Xu LW, et al. Navigating traditional chinese medicine network pharmacology and computational tools[J]. Evidence-based Complement Altern Med,2013, 2013:731969.
    [5] 薛潇春,胡晋红.网络药理学的研究方法与应用进展[J].药学实践杂志,2015,33(5):401-405.
    [6] 周文霞,王同兴,程肖蕊,等. 网络药理学研究中的网络构建技术[J].国际药学研究杂志,2016,43(5):791-812.
    [7] 何艳,于云莉,杨帆.基于复杂网络可视化的癫痫患者大脑状态研究[J]. 中国医疗设备,2016,31(9):39-42.
    [8] Lecca P, Re A. Network-oriented approaches to anticancer drug response[J]. Cancer Gene Networks,2016,03:101-117.
    [9] 周文霞,王同兴,程肖蕊,等.网络药理学研究中的网络分析技术[J].国际药学研究杂志,2016,43(3):399-409.
    [10] Li B,Xu X,Wang X, et al. A systems biology approach to understanding the mechanisms of action of Chinese herbs for treatment of cardiovascular disease[J]. Int J Molecul Sci,2012,13(10):13501-13520.
    [11] Tao W, Xu X, Wang X, et al. Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease[J].J Ethnopharmacol,2013, 145(1):1-10.
    [12] Li X, Wu L, Liu W, et al.A networkpharmacology study of Chinese medicine QiShenYiQi to reveal its underlying multi-compound, multi-target, multi-pathway mode of action[J]. PloS ONE,2014, 9(5):e95004.
    [13] Fang HY, Zeng HW, Lin LM, et al. A network-based method for mechanistic investigation of Shexiang Baoxin Pill's treatment of cardiovascular diseases[J]. Sci Rep, 2017,7:43632.
    [14] Hong M, Wang N,Feng Y,et al. A Biomedical investigation of the hepatoprotective effect of Radix salviae miltiorrhizae and network pharmacology-based prediction of the active compounds and molecular targets[J]. Int J Molecul Sci,2017,18(3):620.
    [15] An L, Feng F.Network pharmacology-based antioxidant effect study of zhi-zi-da-huang decoction for alcoholic liver disease[J]. Evidence-based Complement Altern Med,2015,2015:492470.
    [16] Zhang B, Lu C, Bai M,et al.Tetramethylpyrazine identified by a network pharmacology approach ameliorates methotrexate-induced oxidative organ injury[J]. J Ethnopharmacol,2015,175:638-647.
    [17] Wei S, Niu M, Wang J, et al.A network pharmacology approach to discover active compounds and action mechanisms of San-Cao Granule for treatment of liver fibrosis[J]. Drug Design Development and Therapy,2016, 10:733-743.
    [18] van Berlo D,Hullmann M,Schins RP.Toxicology of ambient particulate matter[J]. Molecul, Clini Environment Toxicol,2012,101:165-217.
    [19] Yu G, Zhang Y, Ren W, et al.Network pharmacology-based identification of key pharmacological pathways of Yin-Huang-Qing-Fei capsule acting on chronic bronchitis[J]. In J Chron Obstruct Pulmon Dis,2017, 12:85-94.
    [20] Hou Y, Nie Y, Cheng B,et al.Qingfei Xiaoyan Wan, a traditional Chinese medicine formula, ameliorates Pseudomonas aeruginosa-induced acute lung inflammation by regulation of PI3K/AKT and Ras/MAPK pathways[J]. Acta Pharmaceutica Sinica B,2016,6(3):212-221.
    [21] Tao J, Hou Y, Ma X,et al. An integrated global chemomics and system biology approach to analyze the mechanisms of the traditional Chinese medicinal preparation Eriobotrya japonica-Fritillaria usuriensis dropping pills for pulmonary diseases[J]. BMC Complement Altern Med,2016,16:4.
    [22] Xiang Z, Sun H, Cai X,et al. The study on the material basis and the mechanism for anti-renal interstitial fibrosis efficacy of rhubarb through integration of metabonomics and network pharmacology[J]. Molecular Biosystems, 2015,11(4):1067-1078.
    [23] Shi SH, Cai YP, Cai XJ, et al. A network pharmacology approach to understanding the mechanisms of action of traditional medicine:Bushenhuoxue formula for treatment of chronic kidney disease[J]. PloS ONE,2014,9(3):e89123.
    [24] Wang J,Yao K,Yang X,et al.Chinese patent medicineliu wei di huang wan combined with antihypertensive drugs, a new integrative medicine therapy, for the treatment of essential hypertension:a systematic review of randomized controlled trials[J]. Evidence-based Complement Altern Med, 2012, 2012:714805.
    [25] Liang X, Li H, Li S. A novel network pharmacology approach to analyse traditional herbal formulae:the Liu-Wei-Di-Huang pill as a case study[J]. Molecular Biosystems,2014,10(5):1014-1022.
    [26] Wang HH,Zhang BX,Ye XT, et al. Study on mechanism for anti-depression efficacy of Sini San through auxiliary mechanism elucidation system for Chinese medicine[J]. Zhongguo Zhong Yao Za Zhi,2015,40(19):3723-3728.
    [27] Margineanu DG. Systems biology, complexity, and the impact on antiepileptic drug discovery[J]. Epilepsy Behav,2014,38:131-142.
    [28] Guo Q, Mao X, Zhang Y,et al. Guizhi-Shaoyao-Zhimu decoction attenuates rheumatoid arthritis partially by reversing inflammation-immune system imbalance[J]. J Transl Med, 2016,14(1):165.
    [29] Zhang Y, Wang D, Tan S, et al. A systems biology-based investigation into the pharmacological mechanisms of wu tou tang acting on rheumatoid arthritis by integrating network analysis[J]. Evidence-based Complement Altern Med,2013,2013:548498.
    [30] Zhang Y, Mao X, Guo Q, et al. Pathway of PPAR-gamma coactivators in thermogenesis:a pivotal traditional Chinese medicine-associated target for individualized treatment of rheumatoid arthritis[J]. Oncotarget,2016,7(13):15885-15900.
    [31] Chen Y, Palczewski K. Systems pharmacology links GPCRs with retinal degenerative disorders[J]. Ann Rev Pharmacol Toxicol,2016,56:273-298.
    [32] Liu H, Zeng L, Yang K. A network pharmacology approach to explore the pharmacological mechanism of Xiaoyao powder on anovulatory infertility[J]. Evidence-based Complement Altern Med,2016,2016:1-13.
    [33] Tang F, Tang Q, Tian Y,et al. Network pharmacology-based prediction of the active ingredients and potential targets of Mahuang Fuzi Xixin decoction for application to allergic rhinitis[J]. J Ethnopharmacol,2015,176:402-412.
  • [1] 朱子凡, 王智聪, 谢彬, 柳润辉.  麝香保心丸“异病同治”2型糖尿病和冠心病的网络药理学作用机制研究 . 药学实践与服务, 2024, 42(4): 173-180. doi: 10.12206/j.issn.2097-2024.202305037
    [2] 陈金涛, 乔子婴, 章祎俊, 许玲, 郑月娟, 何宗阳, 刘良善, 马明华, 张若曦, 王振伟, 年华.  基于网络药理学、分子对接研究金芪清疏颗粒治疗CAP的潜在机制 . 药学实践与服务, 2024, 42(): 1-9. doi: 10.12206/j.issn.2097-2024.202312014
    [3] 姜涛, 徐卫凡, 蒋益萍, 夏天爽, 辛海量.  巴戟天丸对Aβ损伤成骨细胞的作用及基于网络药理学的机制研究 . 药学实践与服务, 2024, 42(): 1-7. doi: 10.12206/j.issn.2097-2024.202305011
    [4] 柯刚, 董清科, 肖世容, 龚茜, 李荣, 汪代杰.  基于网络药理学探讨参苓白术散治疗肿瘤恶病质的作用机制研究 . 药学实践与服务, 2024, 42(3): 1-9. doi: 10.12206/j.issn.2097-2024.202208115
    [5] 朱鑫宇, 白浩然, 赵娜萍, 戚大川, 卫立辛, 张黎.  基于网络药理学探明八宝丹治疗原发性肝癌的潜在机制研究 . 药学实践与服务, 2024, 42(4): 157-164. doi: 10.12206/j.issn.2097-2024.202401061
    [6] 王吉荣, 史小飞, 种育晖, 贾令茹, 万雪莹, 李睿旻.  基于网络药理学与分子对接技术对白术-半夏-茯苓配伍治疗胰腺癌作用机制的研究 . 药学实践与服务, 2023, 41(10): 616-624. doi: 10.12206/j.issn.2097-2024.202306022
    [7] 张敏, 汪晓河, 周阳云, 石美智, 韩忻云, 韩向晖, 陈君君.  基于网络药理学和分子对接的苦参抗乳腺癌潜在机制研究 . 药学实践与服务, 2023, 41(12): 722-732. doi: 10.12206/j.issn.2097-2024.202302001
    [8] 孟祥庆, 李丽华, 王宏瑞, 贾丹, 贾敏.  基于网络药理学和反向分子对接的西红花抗肿瘤作用机制研究 . 药学实践与服务, 2023, 41(3): 160-167, 196. doi: 10.12206/j.issn.2097-2024.202206066
    [9] 王智聪, 谢彬, 袁星, 徐希科, 柳润辉.  基于网络药理学探讨麝香保心丸治疗动脉粥样硬化作用机制 . 药学实践与服务, 2023, 41(5): 296-301. doi: 10.12206/j.issn.2097-2024.202112001
    [10] 黄晴, 施春燕.  基于网络药理学研究白芍治疗肝纤维化的作用机制 . 药学实践与服务, 2023, 41(8): 485-491. doi: 10.12206/j.issn.2097-2024.202208040
    [11] 张倩, 郭羽晨, 邓珊珊, 章越凡, 李铁军.  基于网络药理学的益母草治疗神经损伤的潜在分子机制研究 . 药学实践与服务, 2022, 40(2): 113-119. doi: 10.12206/j.issn.1006-0111.202105106
    [12] 辛宝, 解方园, 姚晨, 葛继芸, 刘静, 张菁, 缪宏, 黄婷婷, 黄玉凤.  基于网络药理学对舒肝宁注射液抗炎保肝作用的机制研究 . 药学实践与服务, 2022, 40(6): 563-570. doi: 10.12206/j.issn.2097-2024.202204049
    [13] 蔡孟成, 金永生, 郑巍, 袁梓珂, 郭良君.  基于网络药理学对降脂护肝胶囊干预脂肪肝的机制研究 . 药学实践与服务, 2021, 39(3): 232-239, 248. doi: 10.12206/j.issn.1006-0111.202006054
    [14] 徐熠, 刘静, 黄瑾, 崔金刚.  基于网络药理学对茵连痛风颗粒抗炎镇痛作用的机制研究 . 药学实践与服务, 2021, 39(3): 226-231, 254. doi: 10.12206/j.issn.1006-0111.202007014
    [15] 蔡孟成, 刘益群, 俞超芹, 金永生.  基于网络药理学与分子对接技术对清开灵干预病毒性感冒的作用机制研究 . 药学实践与服务, 2021, 39(3): 193-202. doi: 10.12206/j.issn.1006-0111.202005077
    [16] 姚茹冰, 彭浩, 蔡孟成, 李霞.  基于网络药理学的青风藤治疗类风湿关节炎的作用机制研究 . 药学实践与服务, 2021, 39(1): 17-22. doi: 10.12206/j.issn.1006-0111.202004117
    [17] 蔡孟成, 俞超芹.  基于网络药理学的金振口服液干预新冠肺炎的机制研究 . 药学实践与服务, 2020, 38(3): 193-201. doi: 10.12206/j.issn.1006-0111.202003163
    [18] 肖志军, 刘萃萃, 陆赛花, 蔡建, 徐峰.  基于网络药理学研究柴胡达胸合剂治疗新型冠状病毒肺炎的作用机制 . 药学实践与服务, 2020, 38(4): 289-295. doi: 10.12206/j.issn.1006-0111.202004023
    [19] 陈俊, 陈青山, 孙森, 赵亮, 张海, 张国庆.  基于网络药理学的肝力保胶囊保肝作用机制研究 . 药学实践与服务, 2018, 36(5): 403-408,416. doi: 10.3969/j.issn.1006-0111.2018.05.005
    [20] 薛潇春, 胡晋红.  网络药理学的研究方法与应用进展 . 药学实践与服务, 2015, 33(5): 401-405. doi: 10.3969/j.issn.1006-0111.2015.05.005
  • 加载中
计量
  • 文章访问数:  4890
  • HTML全文浏览量:  771
  • PDF下载量:  1162
  • 被引次数: 0
出版历程
  • 收稿日期:  2017-09-11
  • 修回日期:  2017-11-03

网络药理学在中药作用机制中的研究进展

doi: 10.3969/j.issn.1006-0111.2018.02.001
    基金项目:  国家自然科学基金(81773683)

摘要: 网络药理学以系统生物学为基础,系统阐述了机体与药物相互作用的原理与规律,代表了现代生物医药的哲学理念与研究模式。运用网络药理学相关的技术手段,更便于理解中药治疗疾病的作用机制,目前网络药理学已被广泛应用于中药研究。从网络药理学及网络药理学应用等方面,介绍近年网络药理学在中药领域的运用与发展。

English Abstract

邢心睿, 吕狄亚, 柴逸峰, 朱臻宇. 网络药理学在中药作用机制中的研究进展[J]. 药学实践与服务, 2018, 36(2): 97-102. doi: 10.3969/j.issn.1006-0111.2018.02.001
引用本文: 邢心睿, 吕狄亚, 柴逸峰, 朱臻宇. 网络药理学在中药作用机制中的研究进展[J]. 药学实践与服务, 2018, 36(2): 97-102. doi: 10.3969/j.issn.1006-0111.2018.02.001
XING Xinrui, LÜ Diya, CHAI Yifeng, ZHU Zhenyu. Advances in the mechanism of Traditional Chinese Medicine by network pharmacology method[J]. Journal of Pharmaceutical Practice and Service, 2018, 36(2): 97-102. doi: 10.3969/j.issn.1006-0111.2018.02.001
Citation: XING Xinrui, LÜ Diya, CHAI Yifeng, ZHU Zhenyu. Advances in the mechanism of Traditional Chinese Medicine by network pharmacology method[J]. Journal of Pharmaceutical Practice and Service, 2018, 36(2): 97-102. doi: 10.3969/j.issn.1006-0111.2018.02.001
参考文献 (33)

目录

    /

    返回文章
    返回